ELTEK LTD.
(Name of Registrant)
Sgoola Industrial Zone,
Petach Tikva, Israel
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________
This Form 6-K is being incorporated by reference into the Registrants Form S-8 Registration Statements File Nos. 333-12012 and 333-123559.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ELTEK LTD. (Registrant) By: /s/ Amnon Shemer Amnon Shemer Chief Financial Officer |
Date: March 26, 2008
ELTEK Ltd.
Amnon Shemer, CFO
+972-3-9395023
amnons@eltek.co.il
Achieves strong sequential revenue
growth in the fourth quarter.
Fourth quarter 2007 revenue of
$9.9 million, up from $8.8 million in Q3-2007
and $8.6 million in
Q2-2007.
PETACH-TIKVA, Israel, March 26, 2007 Eltek Ltd. (NasdaqCM:ELTK), the leading Israeli manufacturer of high-end Printed Circuit Boards (PCBs), including flex-rigid, HDI, and multi-layered boards, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2007. |
In the fourth quarter Eltek made significant progress to increase revenue and to rapidly overcome the adverse revenue impact of a discontinued customer product. Fourth quarter revenue grew to $9.9 million from $8.8 million in the third quarter. Revenue growth in the fourth quarter was driven, in part, by continued penetration of the highend PCB market in the U.S. This market includes customers in the aerospace, industrial and medical industries who have growing demands for Elteks flex-rigid capabilities. In 2007, Elteks strategic penetration of the U.S. highend PCB market substantially gained momentum, by nearly doubling its U.S. revenues to $4.3 million and by winning 13 new tier-one customers.
In the fourth quarter the Company made an important step forward in its efforts to rapidly overcome the adverse revenue impact of the end-of-life notice regarding the principal product of a former customer. Excluding sales relating to the former customers discontinued product, revenues in the twelve-month period ended December 31, 2007 increased by $4.9 million compared to the same period in 2006, reflecting an annual growth rate of 17%. Moreover, the Company made progress in diversifying its customer base, as its largest affiliated group of customers accounted for 15% of total revenues, and no other single customer accounted for more than 10% of total revenues in the fourth quarter or full year 2007.
1
Year Ended December 31, 2007:
Revenues for the twelve-month period ended December 31, 2007 were $37.5 million compared with revenues of $39.0 million for the comparable period in 2006. The year-over-year decrease in revenues is attributable to reduced sales to the Companys former largest customer, which notified the Company at the end of the second quarter of 2007 that it was terminating production of its principal product. Revenues from that customer were $3.4 million in the year ended December 31, 2007 compared to $9.9 million in the year and quarter ended December 31, 2006.
Net loss for the year ended December 31, 2007 was $301,000, or diluted net loss of $0.05 per share, compared with a net profit of $1.7 million, or diluted net profit of $0.24 per share, for the same period in 2006. The reduction in net profit is mainly attributable to the negative impact of the devaluation of the U.S. dollar against the NIS and to the previously mentioned reduction in sales. The Companys sales are primarily denominated in dollars while its expenses are mainly denominated in NIS. During the year ended December 31, 2007 the U.S. dollar decreased in value against the NIS by 9.0%.
Fourth-Quarter 2007:
Eltek reported revenues for the three months ended December 31, 2007 of $9.9 million compared with $8.8 million for the third quarter of 2007, $8.6 million for the second quarter of 2007, and $10.1 million for the fourth quarter of 2006. The slight year-over-year decrease in revenues is attributable to reduced sales to the Companys former principal customer.
The Company incurred a net loss in the fourth quarter of $472,000, or diluted net loss of $0.07 per share, compared with net profit of $63,000, or diluted net profit of $0.01 per share, for the same quarter in 2006. The loss is mainly attributable to continued devaluation of the U.S. dollar against the NIS and, to the aforementioned reduction in sales.
EBITDA:
In the year ended December 31, 2007, Elteks EBITDA was $2.1 million compared with EBITDA of $5.1 million in the same period in 2006. In the fourth quarter of 2007, Elteks EBITDA was $113,000 compared to EBITDA of $1.5 million in the fourth quarter of 2006. The reduction in EBITDA is mainly attributable to the reasons described above.
2
Eltek uses EBITDA as a non-GAAP financial performance measurement. EBITDA is calculated by adding back to net profit (loss), interest, taxes, depreciation and impairment loss. EBITDA is provided to investors to complement results provided in accordance with GAAP, as management believes the measure helps illustrate underlying operating trends in the Companys business and uses the measure to establish internal budgets and goals, manage the business and evaluate performance. EBITDA should not be considered in isolation or as a substitute for comparable measures calculated and presented in accordance with GAAP.
Effective January 1, 2007 the Company is reporting under U.S. GAAP. All comparative data was adjusted accordingly and is presented in these financial statements in accordance with U.S. GAAP. Also effective January 1, 2007, the Company changed its reporting currency from NIS to the U.S. dollar. The change in reporting currency was accounted for in accordance with Financial Accounting Standards (SFAS) No. 52, Foreign Currency Translation (SFAS No. 52). Assets and liabilities of the Company have been translated using the exchange rate at the balance sheet date except for equity accounts which were translated using historical exchange rates. The average exchange rate for the period has been used to translate revenues and expenses. Translation adjustments were reported separately as a component of comprehensive income (cumulative translation adjustment). The Company believes that presenting the financial statements in U.S. dollars and under US-GAAP delivers more meaningful and relevant financial information to its shareholders.
Management Comments:
Arieh Reichart, President and Chief Executive Officer of Eltek, commented: In the fourth quarter we made an important step forward in our efforts to rapidly overcome the adverse revenue impact of the discontinued customer product, as fourth quarter revenue grew nicely over the third quarter. This achievement is a further testament to the continuing strengthening of our global market position as well as to the robustness of our growth strategy.
In 2007, our penetration into the strategic U.S. highend PCB market substantially gained momentum. We nearly doubled our U.S. revenues to $4.3 million, won 13 new tier-one customers, and expanded our distributor network. Based on recent wins and marketing initiatives, we currently believe that we will continue to grow our U.S. revenues in 2008.
Since the second quarter, we obtained sufficient orders from new and existing customers to almost completely compensate for the reduction in sales associated with the former principal customer and are now very encouraged with our progress in diversifying our serial production customer base. Our top ten customers accounted for 48% of our total sales in 2007 as compared with 60% and 63% in the years ended December 31, 2006 and 2005, respectively. In addition, although our operating measures are in line with the industry for the high-end products, we are working on improving our manufacturing processes in order to achieve better operating performance, and expect to see the positive outcome from these steps in the second quarter of 2008 and onwards.
3
Amnon Shemer, CFO of Eltek, added: As an Israelibased exportfocused company, whose domestic prices are also denominated in U.S. dollars, the unprecedented devaluation of the U.S. dollar against the NIS had an inevitable negative impact on our operating margins and profitability. While we have been proactive in entering into hedging transactions, these transactions are of a short term nature, and the magnitude of the devaluation took its toll and adversely offset operational leverage related profitability improvements. The dollar has continued to decline against the NIS in 2008. However, we have recently been working diligently with many of our Israeli clients to increase the actual exchange rate underlying our price lists, and are encouraged by the responsiveness and understanding we have been receiving on this front. We expect to see the positive outcome from these steps in the second quarter of 2008 and onwards.
The severe devaluation of the U.S. dollar against the NIS had a negative impact on our operating margins, as the average exchange rate between the NIS and the U.S. dollar in 2007 and in the fourth quarter of 2007 was 7.7% and 7.4% lower than that of 2006 and the fourth quarter of 2006, respectively. On the other hand, we recorded income of $124,000 in Q4-2007 from hedging transactions, as compared to income of $349,000 in Q3-2007.
Eltek is Israels leading manufacturers of printed circuit boards (PCBs), the core circuitry of most electronic devices. It specializes in the complex high-end of PCB manufacturing, i.e., flex-rigid, HDI, and multi-layered boards. Elteks technologically advanced circuitry solutions are used in todays increasingly sophisticated and compact electronic products. For more information, visit Elteks internet site at www.eltekglobal.com.
Forward Looking Statement:
Certain matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, statements regarding expected results in future periods risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors which are all detailed in the Companys Annual Report on Form 20-F and other filings
4
Eltek ltd.
Consolidated Balance Sheets
(In thousands US$)
December 31, |
||||||||
---|---|---|---|---|---|---|---|---|
2006 |
2007 | |||||||
Audited |
Unaudited | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | 2,030 | 2,467 | ||||||
Receivables: Trade | 7,707 | 8,173 | ||||||
Other | 261 | 742 | ||||||
Inventories | 3,766 | 4,271 | ||||||
Prepaid expenses | 192 | 204 | ||||||
Total current assets | 13,956 | 15,857 | ||||||
Assets held for employees' severance benefits | 1,106 | 1,319 | ||||||
Fixed assets, less accumulated depreciation | 8,143 | 10,997 | ||||||
Goodwill | 903 | 1,009 | ||||||
Total assets | 24,108 | 29,182 | ||||||
Liabilities and Shareholder's equity | ||||||||
Current liabilities | ||||||||
Short-term credit and current maturities of long-term debts | 2,776 | 4,623 | ||||||
Trade payables | 5,941 | 7,354 | ||||||
Other liabilities and accrued expenses | 3,114 | 3,147 | ||||||
Convertible note | 436 | - | ||||||
Total current liabilities | 12,267 | 15,124 | ||||||
Long-term liabilities | ||||||||
Long term debt, excluding current maturities | 3,068 | 4,243 | ||||||
Employee severance benefits | 1,187 | 1,388 | ||||||
Total liabilities | 16,522 | 20,755 | ||||||
Minority interests | 311 | 353 | ||||||
Shareholders' equity | ||||||||
Ordinary shares, NIS 0.6 par value authorized | ||||||||
50,000,000 shares, issued and outstanding 6,609,807 | ||||||||
as of December 31, 2007and 5,624,011 as of | ||||||||
December 31, 2006 | 1,236 | 1,384 | ||||||
Additional paid-in capital | 14,152 | 14,328 | ||||||
Cumulative translation adjustment related to change in | ||||||||
reporting currency | 1,671 | 2,412 | ||||||
Cumulative foreign currency translation adjustments | 416 | 451 | ||||||
Capital reserve | 695 | 695 | ||||||
Accumulated deficit | (10,895 | ) | (11,196 | ) | ||||
Total shareholders equity | 7,275 | 8,074 | ||||||
Total liabilities and shareholders equity | 24,108 | 29,182 | ||||||
5
Eltek ltd.
Consolidated Statements of Operations
(In thousands US$, except per share data)
Year ended |
Three months ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
December 31, |
December 31, | |||||||||||||
2006 |
2007 |
2006 |
2007 | |||||||||||
Audited |
Unaudited |
Unaudited |
Unaudited | |||||||||||
Revenues | 39,045 | 37,476 | 10,143 | 9,889 | ||||||||||
Costs of revenues | (30,557 | ) | (31,879 | ) | (7,680 | ) | (8,994 | ) | ||||||
Gross profit | 8,488 | 5,597 | 2,463 | 895 | ||||||||||
Research and development income (expenses), net | (154 | ) | (74 | ) | (45 | ) | 25 | |||||||
Selling, general and administrative expenses | (5,580 | ) | (5,683 | ) | (1,643 | ) | (1,377 | ) | ||||||
Impairment loss on goodwill | (473 | ) | 0 | (473 | ) | 0 | ||||||||
Operating profit (loss) | 2,281 | (160 | ) | 302 | (457 | ) | ||||||||
Financial expenses, net | (538 | ) | (145 | ) | (141 | ) | (31 | ) | ||||||
Profit (loss) before other income (loss), net | 1,743 | (305 | ) | 161 | (487 | ) | ||||||||
Other income (expenses), net | 5 | 8 | (2 | ) | 3 | |||||||||
Profit (loss) before tax expenses | 1,748 | (297 | ) | 159 | (484 | ) | ||||||||
Income tax expenses | (158 | ) | 0 | (158 | ) | 0 | ||||||||
Profit (loss) after taxes on income | 1,590 | (297 | ) | 1 | (484 | ) | ||||||||
Minority interests | 60 | (4 | ) | 62 | 12 | |||||||||
Net profit (loss) for the period | 1,650 | (301 | ) | 63 | (472 | ) | ||||||||
Basic net earnings (loss) per ordinary share | 0.29 | (0.05 | ) | 0.01 | (0.07 | ) | ||||||||
Diluted net earnings (loss) per ordinary share | 0.24 | (0.05 | ) | 0.01 | (0.07 | ) | ||||||||
Weighted average number of ordinary shares | ||||||||||||||
used to compute basic net earnings (loss) | ||||||||||||||
per ordinary share (in thousands) | 5,617 | 6,247 | 5,624 | 6,610 | ||||||||||
Weighted average number of ordinary shares | ||||||||||||||
used to compute diluted net earnings (loss) | ||||||||||||||
per ordinary share (in thousands) | 6,954 | 6,247 | 6,961 | 6,610 | ||||||||||
6
Non-GAAP Earnings Reconcilliations
Year ended |
Three months ended | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
December 31, |
December 31, |
||||||||||||||||
2006 |
2007 |
2006 |
2007 | ||||||||||||||
Unaudited |
Unaudited |
Unaudited |
Unaudited | ||||||||||||||
GAAP net profit (loss) | 1,650 | (301 | ) | 63 | (472 | ) | |||||||||||
Add back items: | |||||||||||||||||
Financial expenses, net | 538 | 145 | 141 | 31 | |||||||||||||
Tax expenses | 158 | 0 | 158 | 0 | |||||||||||||
Impairment loss on goodwill | 473 | 0 | 473 | 0 | |||||||||||||
Depreciation | 2,330 | 2,264 | 657 | 554 | |||||||||||||
Adjusted EBITDA | 5,149 | 2,107 | 1,491 | 113 | |||||||||||||
7